WASHINGTON — A new report out from AARP today provides additional insight into the impact of a historic new financial protection for our nation’s nearly 55 million Medicare drug plan enrollees. For the first time ever, beginning January 1, 2025, Medicare drug plans will limit enrollees’ annual out-of-pocket spending to $2,000, thanks to a provision in the 2022 Inflation Reduction Act that AARP championed. Specifically, the report shows that 94% of all Part D enrollees expected to reach the new cap in 2025 will have lower total (i.e., premiums and cost sharing) out-of-pocket costs, saving an average of $2,474 nationally. The report also provides state-level data and estimates that 95% of Part D enrollees who will reach the out-of-pocket cap will have lower out-of-pocket health costs in 33 states plus the District of Columbia.

List prices for the 25 top Medicare Part D drugs not currently selected for Medicare drug price negotiation have increased by an average of 98 percent—or nearly doubled—since they first entered the market, according to a new report from AARP’s Public Policy Institute released today. The report also found that, on average, more than 40 percent of the current list prices for the top 25 drugs is due to price increases that have occurred after the products first entered the market. These findings highlight the importance of a 2022 law that addresses high prescription drug prices and drug price increases.

SEATTLE — Today, AARP, the Alzheimer’s Disease Data Initiative (AD Data Initiative), and the Institute for Health Metrics and Evaluation (IHME) at the University of Washington announced the Dementia Risk Reduction Project, a new collaboration to study how factors -- air pollution, alcohol use, depression, diabetes, high body mass index, hearing loss, hypertension, low education, physical inactivity, social isolation, smoking, and traumatic brain injury—vary by state and their correlation to dementia. The research will explore causal links between each factor and dementia, providing valuable information for both consumers and policymakers to address dementia risks in their communities.

According to a new AARP survey exploring the second half of life, most older adults have an optimistic outlook on life and expect their lives to improve as they get older. Nearly 9 in 10 are at least somewhat optimistic about their future, with half being extremely or very optimistic.

WASHINGTON—Today, AARP released a new report detailing the savings from an important new protection for our nation’s 56 million Medicare drug plans enrollees. The savings, thanks to a provision in the 2022 Inflation Reduction Act that AARP championed, will cap out-of-pocket prescription drug costs every year, beginning at $2,000 in January 2025. The report analyzes the number of enrollees that will benefit from the cap by state, age, gender, and race between 2025 and 2029. The findings indicate that Medicare drug plan enrollees who reach the new out-of-pocket cap will see average savings of roughly $1,100, or 56%, in 2025 for their prescription drugs.

Today, AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services (CMS) announcement of the first Medicare negotiated drug prices as part of the 2022 prescription drug law:

Today, AARP – on behalf of the Global Council on Brain Health -- released the ‘Special Report: Hearing Matters for Brain Health,’ highlighting the importance of addressing hearing loss to promote communication and social engagement and reduce the possibility of cognitive decline and dementia. This report comes at a critical time as the growing body of evidence is clear: social isolation and loneliness, which can be associated with hearing loss, are a public health threat. According to U.S. Surgeon General Dr. Vivek Murphy, the U.S. is in the midst of a loneliness and social isolation epidemic, increasing the risk of premature death and can be as detrimental as smoking up to 15 cigarettes a day.

WASHINGTON-- AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services final...

Today, AARP and The DAISY Foundation announced a collaboration between the two organizations to recognize the value of nurses to help improve nursing job satisfaction and retain more nurses in the profession. New data released by AARP today found that 96% of Americans aged 50 + believe more should be done to recognize the value of nurses.

Today, AARP CEO Jo Ann Jenkins issued the following statement in response to President Biden’s State of the Union address:

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today after the Food and Drug Administration (FDA) gave approval for Florida to begin taking the steps needed to import prescription drugs from Canada.

“The court’s decision to allow Medicare drug price negotiations to move forward is welcome news. Pausing Medicare negotiations would have risked billions of dollars in savings for taxpayers...

AARP and AARP Foundation submitted an amicus brief for consideration today in the U.S. District Court for the District of Columbia, urging the court to dismiss Merck & Co.’s lawsuit challenging Medicare’s historic new authority to negotiate lower prescription drug prices.

AARP and AARP Foundation filed an amicus brief today in the U.S. District Court for the Southern District of Ohio, urging the court to dismiss the U.S. Chamber of Commerce’s attempt to block Medicare’s historic new authority to negotiate lower prescription drug prices.

AARP CEO Jo Ann Jenkins issued the following statement in response to President Biden’s State of the Union speech this evening

To help lessen the impact of social isolation on Valentine’s Day, Wish of a Lifetime from AARP’s 10th annual Cupid Crew will hand deliver over 100,000 roses to older adults.

The Centers for Medicare & Medicaid Services (CMS) released the 2023 premiums and deductibles for the Medicare Part B programs earlier today. Medicare Part B premiums will decrease by $5.20 to $164.90 next year, and deductibles will decrease $7 to $226. AARP had called for CMS to lower Part B premiums following a decline in the price and coverage of Aduhelm, which accounted for half of the premium increase in 2022.

The Food and Drug Administration today announced the creation of a new category of over-the-counter (OTC) hearing aids – a move that is expected to lower costs for many consumers and help those with mild to moderate hearing loss.

AARP issued the following statement from Jo Ann Jenkins, AARP Chief Executive Officer, following the House passage of the Inflation Reduction Act of 2022

WASHINGTON— AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to reports that the U.S. Senate is ready to advance a...

Today AARP announced the results of its annual survey, Mirror/Mirror: Women’s Reflections on Beauty, Age and Media™. The study reveals that women who experience discrimination regularly rate their current mental health lower, on average, than those who do not, and that age, race, ethnicity and/or skin tone, as well as weight are the most common types of discrimination reported.

A new AARP national survey shows many LGBTQ adults age 45 and over have concerns about aging, with worries about having enough money in retirement, discrimination and a lack of family support topping the list.

While three-quarters or more of those 60 and over have at least one serious health condition, nearly half rate their health as very good or excellent, according to new research from AARP in collaboration with National Geographic Partners.

AARP hosted a “People’s Hearing” on prescription drugs May 18, featuring seniors from across the United States who struggle to afford their medications along with other basic needs. In addition to sharing how the cost of prescription drugs affects them, participants urged Congress to act now and pass needed reforms.